Exact Sciences is a leading, global cancer diagnostics company with over 6,500 employees worldwide. Our common aim is to eradicate cancer -- and the suffering it causes -- with tests that help in preventing cancer, detecting it earlier, and guiding treatment to provide life-changing value to patients. Building on the success of the Oncotype DX® and the Cologuard® tests, Exact Sciences is investing in its product pipeline to support patients before and throughout their cancer diagnosis and treatment. We serve patients in more than 90 countries and are rapidly building an even stronger international business to bring our tests to patients around the world. For more information on Exact Sciences, please visit the company’s website (www.exactsciences.com/uk) and follow us on Twitter (@ExactSciences), Facebook or LinkedIn (Exact-sciences). To learn more about the Oncotype DX test, please visit the product website or phone us on 020 3031 8087.